CYCLOPHOSPHAMIDE (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the CYCLOPHOSPHAMIDE drug offered from Baxter Healthcare Corporation. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
| NON-PROPRIETARY NAME: | Cyclophosphamide |
| SUBSTANCE NAME: | CYCLOPHOSPHAMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | INTRAVENOUS; ORAL |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1959-11-16 |
| END MARKETING DATE: | 0000-00-00 |
CYCLOPHOSPHAMIDE HUMAN PRESCRIPTION DRUG Details:
| Item Description | CYCLOPHOSPHAMIDE from Baxter Healthcare Corporation |
| LABELER NAME: | Baxter Healthcare Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/25mL) |
| START MARKETING DATE: | 1959-11-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10019-988_76d5deb7-d964-4337-9bd3-dff91437a43d |
| PRODUCT NDC: | 10019-988 |
| APPLICATION NUMBER: | NDA012142 |
Other CYCLOPHOSPHAMIDE Pharmaceutical Manufacturers / Labelers:
